Eguchi K - Search Results

1

Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma.

Kato Y, Hamasaki K, Aritomi T, Nakao K, Nakata K, Eguchi K. Kato Y, et al. Among authors: eguchi k. Oncol Rep. 1999 Nov-Dec;6(6):1273-6. doi: 10.3892/or.6.6.1273. Oncol Rep. 1999. PMID: 10523695

2

Prevalence and characterization of hepatitis C virus in hemodialysis patients.

Morikawa T, Nakata K, Hamasaki K, Tsuruta S, Kato Y, Nakao K, Ohtsubo T, Eguchi K. Morikawa T, et al. Among authors: eguchi k. Intern Med. 1999 Aug;38(8):626-31. doi: 10.2169/internalmedicine.38.626. Intern Med. 1999. PMID: 10440497 Free article.

3

Use of FDP and F1P aldolase to detect tumorous and nontumorous tissue damage by ethanol injection of hepatocellular carcinoma.

Khan KN, Nakata K, Nakao K, Kato Y, Eguchi K. Khan KN, et al. Among authors: eguchi k. Dig Dis Sci. 1999 Aug;44(8):1610-8. doi: 10.1023/a:1026623312806. Dig Dis Sci. 1999. PMID: 10492142

4

Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan.

Kato Y, Nakao K, Hamasaki K, Kato H, Nakata K, Kusumoto Y, Eguchi K. Kato Y, et al. Among authors: eguchi k. J Gastroenterol. 2000;35(3):201-5. doi: 10.1007/s005350050331. J Gastroenterol. 2000. PMID: 10755689

5

Diverse regulations of albumin gene expression by hepatocyte growth factor in HepG2 human hepatoma cells and primary culture of rat hepatocytes.

Iseki K, Nakao K, Nakata K, Shima Y, Hamasaki K, Kato Y, Ishii N, Eguchi K. Iseki K, et al. Among authors: eguchi k. Int J Oncol. 2000 Jun;16(6):1141-5. doi: 10.3892/ijo.16.6.1141. Int J Oncol. 2000. PMID: 10811987

6

Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.

Kato Y, Nakata K, Omagari K, Kusumoto Y, Mori I, Furukawa R, Tanioka H, Tajima H, Yano M, Eguchi K. Kato Y, et al. Among authors: eguchi k. Intern Med. 2001 Jan;40(1):5-8. doi: 10.2169/internalmedicine.40.5. Intern Med. 2001. PMID: 11201371 Free article.

7

Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma.

Shibata Y, Nakata K, Tsuruta S, Hamasaki K, Hayashida Y, Kato Y, Nakao K, Eguchi K. Shibata Y, et al. Among authors: eguchi k. Int J Oncol. 1999 Jun;14(6):1153-6. doi: 10.3892/ijo.14.6.1153. Int J Oncol. 1999. PMID: 10339672

8

Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.

Hida D, Nakata K, Shima Y, Migita K, Nakao K, Kato Y, Ishii N, Eguchi K. Hida D, et al. Among authors: eguchi k. Anticancer Res. 1998 Nov-Dec;18(6A):4317-22. Anticancer Res. 1998. PMID: 9891485

9

Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.

Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K. Ishikawa H, et al. Among authors: eguchi k. Gene Ther. 1999 Apr;6(4):465-70. doi: 10.1038/sj.gt.3300870. Gene Ther. 1999. PMID: 10476206

10

p48 (ISGF-3gamma) is involved in interferon-alpha-induced suppression of hepatitis B virus enhancer-1 activity.

Nakao K, Nakata K, Yamashita M, Tamada Y, Hamasaki K, Ishikawa H, Kato Y, Eguchi K, Ishii N. Nakao K, et al. Among authors: eguchi k. J Biol Chem. 1999 Oct 1;274(40):28075-8. doi: 10.1074/jbc.274.40.28075. J Biol Chem. 1999. PMID: 10497156 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,873 results

Search Page

Filters